Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors

INTRODUCTION: Oral antidiabetes medications, including dipeptidyl peptidase-4 inhibitors (DPP-4is) saxagliptin and sitagliptin, are used for the treatment of type 2 diabetes (T2D). The study objective was to compare all-cause and diabetes-related costs following initiation of saxagliptin or sitaglip...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Adv Ther
Autori principali: Farr, Amanda M., Sheehan, John J., Brouillette, Matthew, Smith, David M., Johnston, Stephen S., Kalsekar, Iftekhar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4735222/
https://ncbi.nlm.nih.gov/pubmed/26724938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0277-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi